Xcelerate (OTCMKTS:XCRT) and Option Care Health (NASDAQ:OPCH) Head-To-Head Contrast

Option Care Health (NASDAQ:OPCH) and Xcelerate (OTCMKTS:XCRT) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Institutional and Insider Ownership

98.1% of Option Care Health shares are held by institutional investors. 0.6% of Option Care Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Option Care Health and Xcelerate”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.00 billion	1.14	$211.82 million	$1.26	28.60
Xcelerate	N/A	N/A	N/A	N/A	N/A

Option Care Health has higher revenue and earnings than Xcelerate.

Profitability

This table compares Option Care Health and Xcelerate’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.78%	17.89%	7.20%
Xcelerate	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Option Care Health and Xcelerate, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	0	3	10	1	2.86
Xcelerate	0	0	0	0	0.00

Option Care Health presently has a consensus target price of $37.50, suggesting a potential upside of 4.08%. Given Option Care Health’s stronger consensus rating and higher possible upside, research analysts plainly believe Option Care Health is more favorable than Xcelerate.

Volatility and Risk

Option Care Health has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, Xcelerate has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500.

Summary

Option Care Health beats Xcelerate on 11 of the 11 factors compared between the two stocks.

About Option Care Health

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

About Xcelerate

Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.